BRAF, FGFR1 AND PDGFRA ALTERATIONS IN OLIGODENDROGLIOMAS - CORRELATION WITH MAPK/MTOR PATHWAY ACTIVATION

被引：0
|
作者：
Sarkar, C. [1 ]
Kumar, A. [2 ,3 ]
Pathak, P. [3 ]
Purkait, S.
Nayak, S. [4 ]
Faruq, M. [5 ]
Suri, V. [6 ]
Sharma, M. C. [6 ]
Suri, A. [2 ]
机构：
[1] All India Inst Med Sci, New Delhi, India
[2] All India Inst Med Sci, Dept Neurosurg, New Delhi, India
[3] All India Inst Med Sci, Dept Pathol, New Delhi, India
[4] All India Inst Med Sci, Deprartment Pathol, New Delhi, India
[5] CSIR IGIB, Dept Genom & Mol Med, New Delhi, India
[6] All India Inst Med Sci, Dept Pathol, New Delhi, India
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P03.22
引用
收藏
页码：38 / 38
页数：1
相关论文
共 50 条
  • [1] Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas
    Kumar, Anupam
    Pathak, Pankaj
    Purkait, Suvendu
    Faruq, Mohammed
    Jha, Prerana
    Mallick, Supriya
    Suri, Vaishali
    Sharma, Mehar C.
    Suri, Ashish
    Sarkar, Chitra
    CANCER GENETICS, 2015, 208 (03) : 91 - 95
  • [2] Hematolymphoid Neoplasms Associated With Rearrangements of PDGFRA, PDGFRB, and FGFR1
    Vega, Francisco
    Medeiros, L. Jeffrey
    Bueso-Ramos, Carlos E.
    Arboleda, Patricia
    Miranda, Roberto N.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (03) : 377 - 392
  • [3] Clinical Indications for PDGFRA/B, or FGFR1 Testing in Hematologic Neoplasms
    Nguyen, Lynh
    Song, Jinming
    Papenhausen, Peter R.
    Zhang, Ling
    MODERN PATHOLOGY, 2017, 30 : 367A - 367A
  • [4] Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB or FGFR1
    Dunphy, Cherie H.
    CURRENT CANCER THERAPY REVIEWS, 2012, 8 (01) : 44 - 51
  • [5] Clinical Indications for PDGFRA/B, or FGFR1 Testing in Hematologic Neoplasms
    Lynh Nguyen
    Song, Jinming
    Papenhausen, Peter R.
    Zhang, Ling
    LABORATORY INVESTIGATION, 2017, 97 : 367A - 367A
  • [6] Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1
    Bain, Barbara J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (05): : 696 - 698
  • [7] Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma
    Pathak, Pankaj
    Kumar, Anupam
    Jha, Prerana
    Purkait, Suvendu
    Faruq, Mohammed
    Suri, Ashish
    Suri, Vaishali
    Sharma, Mehar C.
    Sarkar, Chitra
    BRAIN PATHOLOGY, 2017, 27 (05) : 580 - 589
  • [8] Actionable FGFR1 and BRAF mutations in adult circumscribed gliomas
    Trisolini, Elena
    El Wardighi, Dounia
    Giry, Marine
    Bernardi, Priscilla
    Boldorini, Renzo Luciano
    Mokhtari, Karima
    Sanson, Marc
    JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (02) : 241 - 245
  • [9] FGFR1 Induces Acquired Resistance Against Gefitinib By Activating AKT/mTOR Pathway In NSCLC
    Zhang, Dan
    Han, Li-li
    Du, Fen
    Liu, Xiao-meng
    Li, Jin
    Wang, Hui-hui
    Song, Ming-hui
    Li, Zeng
    Li, Guo-yin
    ONCOTARGETS AND THERAPY, 2019, 12 : 9809 - 9816
  • [10] Actionable FGFR1 and BRAF mutations in adult circumscribed gliomas
    Elena Trisolini
    Dounia El Wardighi
    Marine Giry
    Priscilla Bernardi
    Renzo Luciano Boldorini
    Karima Mokhtari
    Marc Sanson
    Journal of Neuro-Oncology, 2019, 145 : 241 - 245
12345